BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22335591)

  • 21. Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study.
    Veras E; Malpica A; Deavers MT; Silva EG
    Int J Gynecol Pathol; 2009 Jul; 28(4):316-21. PubMed ID: 19483635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.
    Puripat N; Loharamtaweethong K
    Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitotic Index Determined by Phosphohistone H3 Immunohistochemistry for Precise Grading in Follicular Lymphoma.
    Bedekovics J; Irsai G; Hegyi K; Beke L; Krenács L; Gergely L; Méhes G
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):579-585. PubMed ID: 27997502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.
    Hale CS; Qian M; Ma MW; Scanlon P; Berman RS; Shapiro RL; Pavlick AC; Shao Y; Polsky D; Osman I; Darvishian F
    Am J Surg Pathol; 2013 Jun; 37(6):882-9. PubMed ID: 23629443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.
    Gunia S; Kakies C; Erbersdobler A; Koch S; May M
    J Clin Pathol; 2012 Aug; 65(8):715-20. PubMed ID: 22554964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.
    Ibrahim A; Toss MS; Makhlouf S; Miligy IM; Minhas F; Rakha EA
    Histopathology; 2023 Feb; 82(3):393-406. PubMed ID: 36349500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of 4 Immunohistochemical Phosphohistone H3 Antibodies for Marking Mitotic Figures in Breast Cancer.
    Focke CM; Finsterbusch K; Decker T; van Diest PJ
    Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):20-26. PubMed ID: 27941557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical characterization of perineal melanoma in Kilis goats.
    Ozyildiz Z; Ceylan C; Yilmaz R; Ozsoy SY
    Biotech Histochem; 2012 Aug; 87(6):408-12. PubMed ID: 22519426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated quantification of Ki67/MART1 stains may prevent false-negative melanoma diagnoses.
    Wandler A; Spaun E; Steiniche T; Nielsen PS
    J Cutan Pathol; 2016 Nov; 43(11):956-962. PubMed ID: 27461337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of tumor mitotic rate in thin metastatic melanomas compared with thin melanomas without metastasis using both the hematoxylin and eosin and anti-phosphohistone 3 IHC stain.
    Thareja S; Zager JS; Sadhwani D; Thareja S; Chen R; Marzban S; Jukic DM; Glass LF; Messina J
    Am J Dermatopathol; 2014 Jan; 36(1):64-7. PubMed ID: 24451214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nottingham-defined mitotic score: comparison with visual and image cytometric phosphohistone H3 labeling indices and correlation with Oncotype DX recurrence score.
    Zbytek B; Cohen C; Wang J; Page A; Williams DJ; Adams AL
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):48-53. PubMed ID: 22495373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.
    Chen X; Maniotis AJ; Majumdar D; Pe'er J; Folberg R
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2533-9. PubMed ID: 12147581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.
    Ribalta T; McCutcheon IE; Aldape KD; Bruner JM; Fuller GN
    Am J Surg Pathol; 2004 Nov; 28(11):1532-6. PubMed ID: 15489659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.
    Uguen A; Conq G; Doucet L; Talagas M; Costa S; De Braekeleer M; Marcorelles P
    Virchows Arch; 2015 Jul; 467(1):47-54. PubMed ID: 25823616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical Staining in the Assessment of Melanoma Tumor Thickness.
    Kamyab-Hesary K; Ghanadan A; Balighi K; Mousavinia SF; Nasimi M
    Pathol Oncol Res; 2020 Apr; 26(2):885-891. PubMed ID: 30875030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serine 2481-autophosphorylation of mammalian target of rapamycin (mTOR) couples with chromosome condensation and segregation during mitosis: confocal microscopy characterization and immunohistochemical validation of PP-mTOR(Ser2481) as a novel high-contrast mitosis marker in breast cancer core biopsies.
    Lopez-Bonet E; Vazquez-Martin A; Pérez-Martínez MC; Oliveras-Ferraros C; Pérez-Bueno F; Bernadó L; Menendez JA
    Int J Oncol; 2010 Jan; 36(1):107-15. PubMed ID: 19956839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
    Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical staining with Melan-A of uninvolved sun-damaged skin shows features characteristic of lentigo maligna.
    Bowen AR; Thacker BN; Goldgar DE; Bowen GM
    Dermatol Surg; 2011 May; 37(5):657-63. PubMed ID: 21446989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
    Lazova R; Tantcheva-Poor I; Sigal AC
    J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.